Thorne HealthTech, Inc. (THRN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Thorne HealthTech, Inc. (THRN) trades at $10.19 with AI Score 50/100 (Grade B). Thorne HealthTech, Inc. is a science-driven wellness company that provides personalized health solutions. Market cap: $550.63M, Sector: Consumer defensive.
Last analyzed: Mar 16, 2026Analyst Coverage for THRN: THRN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates THRN against Consumer Defensive peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
THRN: 4/7 perspectives are bullish. Dominant signal: Jim Simons bullish.
Thorne HealthTech, Inc. (THRN) Consumer Business Overview
Thorne HealthTech provides personalized wellness solutions through health tests, nutritional supplements, and education. Leveraging its Onegevity platform, Thorne caters to healthcare professionals, athletes, and consumers seeking proactive health management, differentiating itself through science-backed, data-driven insights in the competitive packaged foods sector.
What Is the Investment Thesis for THRN?
Thorne HealthTech presents a compelling investment thesis centered on the growing demand for personalized wellness solutions. With a market capitalization of $0.55 billion and a P/E ratio of 34.30, Thorne demonstrates profitability with a 6.9% profit margin and a 50.2% gross margin. Key growth drivers include expanding its health test offerings, scaling the Onegevity platform, and increasing penetration within its core customer segments. The company's focus on science-backed solutions and data-driven personalization positions it favorably in a market increasingly driven by consumer interest in preventative health. However, potential risks include competition from established players in the supplement industry and the need to continuously innovate to maintain its technological edge. The company's beta of 0.82 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
THRN Key Highlights
- Market Cap of $0.55B indicates a mid-sized company in the packaged foods sector.
- P/E ratio of 34.30 suggests investors are paying a premium for Thorne's earnings, reflecting growth expectations.
- Profit Margin of 6.9% demonstrates profitability, although it could be improved compared to industry leaders.
- Gross Margin of 50.2% indicates strong pricing power and efficient cost management in its product offerings.
- Beta of 0.82 suggests the stock is less volatile than the overall market, potentially appealing to risk-averse investors.
Who Are THRN's Competitors?
THRN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CLXT Calyxt, Inc. | $6.30 | +5.53% | $31.33M | 43 |
| FREE Whole Earth Brands, Inc. | $4.87 | -0.20% | $211.57M | 42 |
| HAPP Happiness Development Group Limited | $4.50 | +1.12% | $31.30M | 45 |
| MAMA Mama's Creations, Inc. | $14.78 | -0.07% | $601.65M | 47 |
| MITC MeaTech 3D Ltd. | $3.34 | -1.47% | $57.47M | 44 |
| GPAGF Gruma, S.A.B. de C.V. | $18.10 | +0.00% | $6.18B | 66 |
| PNGAF Pangea Wellness Inc. | $0.36 | +5.92% | $5.45M | 65 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.75M | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are THRN's Key Strengths?
- Science-backed approach and data-driven insights.
- Strong brand reputation and customer loyalty.
- Proprietary Onegevity platform.
- Established relationships with healthcare professionals and athletes.
What Are THRN's Weaknesses?
- Relatively small market capitalization compared to larger competitors.
- Limited international presence.
- Reliance on key customer segments.
- Potential for regulatory scrutiny of health claims.
What Could Drive THRN Stock Higher?
- Launch of new health test offerings targeting specific health conditions.
- Expansion of the Onegevity platform with enhanced data analytics capabilities.
- Increased adoption of Thorne's products and services by healthcare professionals and athletes.
- Strategic partnerships with telehealth providers and fitness apps.
What Are the Key Risks for THRN?
- Competition from established players in the supplement industry.
- Evolving consumer preferences and trends.
- Regulatory scrutiny of health claims.
- Economic downturn impacting consumer spending on discretionary items.
- Product liability claims.
What Are the Growth Opportunities for THRN?
- Expansion of Health Test Offerings: Thorne can capitalize on the growing demand for personalized health insights by expanding its range of health tests. This includes developing new tests for specific biomarkers, health conditions, and lifestyle factors. The market for personalized health testing is projected to reach billions of dollars by 2030, driven by advancements in genomics and data analytics. By offering a comprehensive suite of tests, Thorne can attract a wider customer base and increase revenue per customer.
- Scaling the Onegevity Platform: The Onegevity platform is a key differentiator for Thorne, providing a unique data-driven approach to personalized wellness. Scaling the platform involves expanding its database of biological data, improving its algorithms, and developing new applications for personalized recommendations. The market for AI-powered health solutions is rapidly growing, with significant opportunities for companies that can leverage data to improve health outcomes. Thorne can partner with healthcare providers and research institutions to further enhance the capabilities of the Onegevity platform.
- Increased Penetration within Core Customer Segments: Thorne has established a strong presence among healthcare professionals, professional athletes, and professional sports teams. Increasing penetration within these segments involves expanding its sales and marketing efforts, developing tailored solutions for specific customer needs, and building stronger relationships with key influencers. The market for sports nutrition and performance enhancement is substantial, with significant opportunities for companies that can provide science-backed solutions. Thorne can leverage its reputation for quality and efficacy to gain a larger share of this market.
- Strategic Partnerships and Acquisitions: Thorne can accelerate its growth by forming strategic partnerships with complementary companies and acquiring innovative startups in the wellness space. This includes partnering with telehealth providers, fitness apps, and personalized nutrition companies to expand its reach and offer integrated solutions. The market for mergers and acquisitions in the wellness industry is active, with significant opportunities for companies to consolidate their position and gain access to new technologies and markets. Thorne can selectively pursue partnerships and acquisitions that align with its strategic goals and enhance its competitive advantage.
- International Expansion: Thorne currently operates primarily in the United States, with limited international presence. Expanding into new international markets represents a significant growth opportunity, particularly in regions with a growing interest in personalized wellness and preventative health. This includes markets in Europe, Asia, and Latin America. International expansion requires adapting its products and services to local regulations and cultural preferences, as well as establishing distribution channels and marketing strategies. By successfully expanding internationally, Thorne can diversify its revenue streams and reduce its reliance on the US market.
What Opportunities Does THRN Have?
- Expansion of health test offerings.
- Scaling the Onegevity platform.
- Strategic partnerships and acquisitions.
- International expansion.
- Growing demand for personalized wellness solutions.
What Threats Does THRN Face?
- Competition from established players in the supplement industry.
- Evolving consumer preferences and trends.
- Potential for product liability claims.
- Economic downturn impacting consumer spending on discretionary items.
What Are THRN's Competitive Advantages?
- Proprietary Onegevity platform providing a data-driven advantage.
- Strong relationships with healthcare professionals and athletes.
- Reputation for science-backed, high-quality products.
- Integrated approach combining diagnostics, supplements, and education.
What Does THRN Do?
Thorne HealthTech, Inc., founded in 1984 and headquartered in New York City, operates as a science-driven wellness company focused on delivering personalized approaches to health and wellness both in the United States and internationally. The company offers a range of health tests spanning sleep, stress, weight management, gut health, heavy metals, and biological age, which generate molecular portraits of individual customers. These tests inform the development of targeted nutritional supplements and personalized wellness education solutions. Thorne's core offering revolves around its proprietary Onegevity platform, which integrates and analyzes biological data to provide actionable insights, personalized products, and services designed to empower individuals to proactively manage and improve their health. The company primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams, positioning itself as a premium provider of science-backed wellness solutions. Thorne's integrated approach, combining diagnostics, supplements, and education, differentiates it from competitors in the broader packaged foods and wellness market.
What Products and Services Does THRN Offer?
- Develops and markets nutritional supplements.
- Offers a range of health tests, including sleep, stress, and gut health assessments.
- Provides personalized wellness education solutions.
- Utilizes the Onegevity platform to analyze biological data.
- Serves healthcare professionals and athletes.
- Offers data-driven insights for proactive health management.
- Provides personalized data, products, and services to improve and maintain health.
How Does THRN Make Money?
- Direct-to-consumer sales of health tests and supplements.
- Partnerships with healthcare professionals and sports teams.
- Subscription-based access to the Onegevity platform and personalized recommendations.
- Revenue from wellness education programs and content.
What Industry Does THRN Operate In?
Thorne HealthTech operates within the rapidly expanding wellness industry, driven by increasing consumer awareness of preventative health and personalized solutions. The market for nutritional supplements and health testing is highly competitive, with established players and emerging startups vying for market share. Thorne differentiates itself through its science-backed approach and the Onegevity platform, which provides a data-driven advantage. The industry is characterized by evolving consumer preferences, regulatory scrutiny, and the need for continuous innovation to maintain relevance. The global wellness market is projected to reach trillions of dollars in the coming years, presenting significant growth opportunities for companies like Thorne.
Who Are THRN's Key Customers?
- Healthcare professionals seeking personalized solutions for their patients.
- Professional athletes and sports teams looking to optimize performance.
- Consumers interested in proactive health management and personalized wellness.
- Individuals seeking to improve their sleep, stress levels, and gut health.
THRN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Thorne HealthTech has seen increased insider buying, indicating confidence from leadership in the company's future prospects.
- Recent social sentiment has shifted positively, with community discussions highlighting Thorne's innovative health solutions gaining traction.
- The growing consumer focus on health and wellness is aligning well with Thorne's product offerings, enhancing market perception.
- Thorne's recent partnerships with health professionals have bolstered its credibility and visibility in the market, attracting more attention from potential customers.
Bear Case
- Despite positive sentiment, some analysts express concerns about Thorne's competitive landscape, which is becoming increasingly crowded.
- There are mixed reviews from the community regarding the effectiveness of Thorne's products, leading to skepticism among some potential buyers.
- Recent supply chain challenges have raised questions about Thorne's ability to meet growing demand, creating uncertainty in operations.
- Market volatility and economic pressures may dampen consumer spending on health products, impacting Thorne's sales in the near term.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
THRN Latest News
No recent news available for THRN.
THRN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for THRN.
Price Targets
Wall Street price target analysis for THRN.
THRN MoonshotScore
What does this score mean?
The MoonshotScore rates THRN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Paul F. Jacobson
CEO
Paul F. Jacobson serves as the CEO of Thorne HealthTech, bringing extensive experience in the health and wellness industry. His background includes leadership roles in various companies focused on consumer health products and personalized nutrition. He has a proven track record of driving growth and innovation in the health and wellness sector. His expertise spans strategic planning, product development, and market expansion. He is responsible for overseeing the company's overall strategy and operations, guiding Thorne's mission to deliver personalized health solutions.
Track Record: Under Paul F. Jacobson's leadership, Thorne HealthTech has focused on expanding its product offerings and strengthening its position in the personalized wellness market. Key achievements include scaling the Onegevity platform and increasing penetration within core customer segments. He has overseen strategic initiatives to drive revenue growth and improve profitability. His leadership has been instrumental in positioning Thorne as a leader in the science-backed wellness space.
Common Questions About THRN (Consumer Defensive)
What does Thorne HealthTech, Inc. do?
Thorne HealthTech, Inc. is a science-driven wellness company providing personalized health solutions. It offers a range of health tests, including sleep, stress, and gut health assessments, which generate molecular portraits of individual customers. These tests inform the development of targeted nutritional supplements and personalized wellness education solutions. Thorne primarily serves healthcare professionals, professional athletes, and consumers seeking proactive health management, differentiating itself through its proprietary Onegevity platform, which integrates and analyzes biological data to provide actionable insights.
What are the main risks for THRN?
The main risks for Thorne HealthTech include competition from established players in the supplement industry, evolving consumer preferences and trends, potential regulatory scrutiny of health claims, and the impact of an economic downturn on consumer spending. Additionally, the company faces the risk of product liability claims and the need to continuously innovate to maintain its technological edge. These risks could impact Thorne's revenue growth, profitability, and market share. Investors should carefully consider these risks before investing in THRN.
How does Thorne HealthTech, Inc. adapt to changing consumer preferences?
Thorne HealthTech adapts to changing consumer preferences by continuously innovating its product offerings and leveraging its Onegevity platform to provide personalized solutions. The company monitors consumer trends and preferences through market research and data analysis, using this information to develop new health tests, nutritional supplements, and wellness education programs. Thorne also utilizes its direct-to-consumer sales channel to gather feedback from customers and adapt its offerings accordingly. By staying agile and responsive to consumer needs, Thorne aims to maintain its competitive edge in the rapidly evolving wellness market.
How does Thorne HealthTech, Inc. ensure the safety and efficacy of its products?
Thorne HealthTech ensures the safety and efficacy of its products through rigorous testing and quality control processes. The company adheres to strict manufacturing standards and utilizes high-quality ingredients in its nutritional supplements. Thorne also conducts clinical trials and research studies to validate the efficacy of its products and health tests. Additionally, the company complies with all relevant regulatory requirements and works closely with healthcare professionals to ensure that its products are safe and effective for consumers. By prioritizing safety and efficacy, Thorne aims to build trust and credibility with its customers.
What are the key factors to evaluate for THRN?
Thorne HealthTech, Inc. (THRN) holds an AI score of 50/100 (moderate). Not financial advice.
How frequently does THRN data refresh on this page?
THRN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven THRN's recent stock price performance?
Thorne HealthTech, Inc. (THRN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Science-backed approach and data-driven insights. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider THRN overvalued or undervalued right now?
Valuing Thorne HealthTech, Inc. (THRN) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for THRN, limiting the depth of some sections.
- Financial data is based on publicly available information and may be subject to change.
- The competitive landscape is dynamic and subject to evolving market conditions.